Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

Long-term outcome and prognosis of mixed histiocytosis (E... | ResearchHub

Paper

Paper

Supporters

Support the authors with ResearchCoin

Journal

EClinicalMedicine

Topics

DOI

10.1016/j.eclinm.2024.102658

Changelog Terms Privacy Issues Docs Support Foundation About

Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)

0

Authors

Francesco Pegoraro

Francesco Pegoraro•Arie Fatoni•Julien Haroche

Published

May 27, 2024

Abstract

Erdheim-Chester disease (ECD) is a rare histiocytosis that may overlap with Langerhans Cell Histiocytosis (LCH). This "mixed" entity is poorly characterized. We here investigated the clinical phenotype, outcome, and prognostic factors of a large cohort of patients with mixed ECD-LCH.

Supporters

Support the authors with ResearchCoin

Journal

EClinicalMedicine

Topics

DOI

10.1016/j.eclinm.2024.102658